Studies on the relationship between B lymphocytes and tumours, especially PC, have majorly focused on direct or indirect molecular targets, such as activation of STAT3 to promote tumour angiogenesis (164)
These guides focus on clinical trial data, real-world insurance coverage, and practical considerations for patients
Proceedings of the National Academy of Sciences, 123 (12), e2517314123
Conclusions and Relevance In this cohort study, most patients with overweight or obesity discontinued GLP-1 RA therapy within 1 year, but those without type 2 diabetes had higher discontinuation rates and lower reinitiation rates
Who Is at Higher Risk for This Side Effect
Focus on the Food and Drug Administrations FDA Adverse Events Reporting System (FAERS) pharmacovigilance dataset